Pharmovigilance of Rituximab Biosimilar in the Treatment of Lymphomas in Argentina

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_195
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy

Oncologist
Cancer ResearchMedicineOncology
2010English

Clinical and Immunological Effects of the Original and Biosimilar Rituximab in Patients With Rheumatoid Arthritis

Clinical pharmacology and therapy
2019English

Rituximab in the Treatment of Antisynthetase Syndrome

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

A New Prognostic Score for AIDS-related Lymphomas in the Rituximab-Era

Haematologica
Hematology
2014English

Gene Polymorphisms as Predictors of Treatment Efficacy and Toxicity in Patients With Indolent Non-Hodgkin Lymphomas Receiving Bendamustine and Rituximab

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Role of Rituximab in Myasthenia Gravis’ Treatment

Journal of Neurology & Stroke
2017English

The Efficacy of Rituximab in the Treatment of Inhibitor-Associated Hemostatic Disorders

Thrombosis and Haemostasis
Hematology
2006English

Off-Label Use of Rituximab in Dermatology: Pemphigus Treatment

Anais Brasileiros de Dermatologia
Dermatology
2013English

Psy111 - Pharmacoeconomic Evaluation of Biosimilar Recombinant Alpha-Epoetin in the Treatment of Anemia in Hemodialysis Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy